| EYE
DROP GROUP |
| NAME OF PRODUCT |
STRENGTH |
PACKING |
| CHLORAMPHENICOL EYE DROP B.P. |
- |
5 ML |
| CIPROFLOXACIN EYE/EAR DROP |
- |
5 ML |
| GENTAMICIN EYE/EAR DROP |
- |
5 ML |
| NORFLOXACIN EYE/EAR DROP |
- |
5 ML |
| OINTMENT
GROUP |
| BETAMETHASONE + NEONYCIN |
- |
15 GM. |
| BETAMETHASONE DIPROPIONATE |
- |
15 GM.. |
| BEBTAMETHASONE VALERATE1% |
- |
15 GM. |
| CLOBETASOLE PROPIONATE 0.05% |
- |
15 GM. |
| CLOTRIMAZOLE 1% |
- |
15 GM. |
| FLUOCINOLANE WITH CHINOFORM |
- |
15 GM. |
| GENTAMYCIN SULPHATE 0.1%% W/W |
- |
15 GM. |
| HYDROCORTISONE ACETATE 25 MG. |
- |
15 GM. |
| MICONAZOLE NITRATE |
- |
15 GM. |
| MICONAZOLE NITRATE WITH FLUOCINLOANE |
- |
15 GM. |
| POVIDONE IODINE 5% |
- |
100 ML. |
| POVIDONE IODINE 5% |
- |
60 ML. |
| POVIDONE IODINE USP 5% W/W |
- |
25 GM. |
| SILVER SULPHADIAZINE CREAM |
- |
15 GM. |
| TETRACYCLINE SKIN
OINTMENT |
- |
15 GM. |
|
|
|
| DRY
SYRUP & LIQUID GROUP |
| AMOXYCILLIN ORAL SUSP. (carton) |
125 MG/5 ML |
100 ML. |
| AMPICILLIN ORAL SUSP. |
125 MG/5 ML |
100 ML. |
| AMPICILLIN + CLOXACILLIN ORAL SUSP. |
125 + 125 MG/5 ML |
100 ML. |
| CEPHALEXIN DRY SYRUP |
125 MG/5 ML |
60 ML. |
| CHLOROQUINE PHOSPHATE SYRUP |
80 MG/5 ML |
60 ML. |
| CHLOROQUINE PHOSPHATE SYRUP |
80 MG/5 ML |
100 ML. |
| CHLOROQUINE PHOSPHATE SYRUP |
80 MG/5 ML |
450 ML. |
| CLOXACILLIN ORAL SUSP. |
125 MG/5 ML |
100 ML. |
| COTRIMOXAZOLE SUSP. |
40MG+200MG. |
50 ML. |
| COTRIMOXAZOLE SUSP. |
40MG+200MG. |
100 ML. |
| CYPROHEPTADINE SYRUP. |
2 MG/5ML |
100 ML. |
| ERYTHROMYCIN STEARATE ORAL. SUSP |
125 MG/5 ML |
100 ML. |
| PARACETAMOL SYRUP |
62.5 MG/5 ML |
60 ML. |
| PARACETAMOL SYRUP |
62.5 MG/5 ML |
100 ML. |
| PARACETAMOL SYRUP |
62.5 MG/5 ML |
450 ML. |
| SALBUTAMOL SYRUP |
2 MG/5ML |
100 ML. |
| |
|
|
|
REJOINDER |
| PRODUCTS ARE NOT OFFERED IN
COUNTRIES WHERE VALID PATENTS EXIST. HOWEVER, FINAL
RESPONSIBILITY WITH RESPECT TO THIRD PARTY PATENT RIGHTS IN A
SPECIFIC COUNTRY LIES EXCLUSIVELY WITH THE USER |
